Medicaid Expansion and Severe Maternal Morbidity
Authors:
- Valeria HernandezVHValeria Hernandez
- John CursioJCJohn Cursio
- L. Phillip SchummLSL. Phillip Schumm
- Debra StulbergDSDebra Stulberg
- Manoradhan MurugesanMMManoradhan Murugesan
- Annie DudeADAnnie Dude
Open Access
- 23 April 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 147 (6) , 885-891
Abstract
OBJECTIVE: To evaluate whether there is an association between state-level Medicaid expansion and severe maternal morbidity (SMM) among Medicaid enrollees who delivered between 2010 and 2018. METHODS: This is a secondary analysis of Medicaid claims that uses national Medicaid analytic files. We included Medicaid enrollees with delivery hospitalizations between 2010 and 2018 in all states that expanded Medicaid under the Affordable Care Act (ACA) by July 2016. The primary outcome was SMM, defined using the Centers for Disease Control and Prevention's validated list of 21 indicators. The primary exposure was whether the enrollee's state of residence had expanded Medicaid 21 months before their delivery under the ACA, to allow for 1 year of expansion before a 9-month pregnancy. We also included analyses that allowed for a 9-month lag after expansion so that Medicaid expansion was in place at the start of a pregnancy. We calculated annual rates of SMM by Medicaid expansion status and analyzed trends across time. We used logistic regression to estimate the association between timing of deliveries relative to Medicaid expansion and SMM at the delivery encounter. RESULTS: Data for 6,976,586 individuals were available for analysis in 30 of the 31 states that expanded Medicaid by July 2016. Rates of SMM trended downward after Medicaid expansion in these states. Individuals who delivered at least 21 months after state Medicaid expansions were significantly less likely to experience SMM relative to those who delivered before Medicaid expansion (including blood transfusion: odds ratio [OR] 0.79; 95% CI, 0.68–0.90; excluding blood transfusion: OR 0.76; 95% CI, 0.65–0.88). CONCLUSION: Medicaid expansion was associated with decreased odds of SMM.Keywords
Funding Information
- Agency for Healthcare Research and Quality (R01 HS028840)
This publication has 18 references indexed in Scilit:
- The T-MSIS Analytic Files (TAF) Analysis Reporting ChecklistJAMA Health Forum, 2025
- Affordable Care Act Medicaid expansions and maternal morbidityHealth Economics, 2023
- Trends in Maternal Mortality and Severe Maternal Morbidity During Delivery-Related Hospitalizations in the United States, 2008 to 2021JAMA Network Open, 2023
- Severe Maternal Morbidity and Mortality Risk at the Intersection of Rurality, Race and Ethnicity, and MedicaidWomen's Health Issues, 2022
- Preconception care and severe maternal morbidity in the United StatesAmerican Journal of Obstetrics & Gynecology MFM, 2021
- Impacts of Medicaid Expansion Before Conception on Prepregnancy Health, Pregnancy Health, and OutcomesAmerican Journal of Epidemiology, 2021
- Insurance Coverage and Perinatal Health Care Use Among Low-Income Women in the US, 2015-2017JAMA Network Open, 2021
- Adoption of Medicaid Expansion Is Associated with Lower Maternal MortalityWomen's Health Issues, 2020
- Measuring severe maternal morbidity: validation of potential measuresAmerican Journal of Obstetrics and Gynecology, 2016
- Racial and ethnic disparities in severe maternal morbidity: a multistate analysis, 2008-2010American Journal of Obstetrics and Gynecology, 2014